UB-312 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05634876 (ClinicalTrials.gov)	April 2023	23/11/2022	UB-312 in Patients With Synucleinopathies	A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies	Multiple System Atrophy;Parkinson Disease	Biological: UB-312 Injection;Biological: Placebo Injection	NYU Langone Health	NULL	Not yet recruiting	40 Years	75 Years	All	8	Phase 1/Phase 2	United States
2	NCT04075318 (ClinicalTrials.gov)	August 29, 2019	5/8/2019	Study of UB-312 in Healthy Participants and Parkinson's Disease Patients	A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UBITh® PD Immunotherapeu ...	Parkinson's Disease;Parkinsonism	Biological: UB-312;Biological: Placebo	United Neuroscience Ltd.	Centre for Human Drug Research, Netherlands;Worldwide Clinical Trials;Vaxxinity, Inc.	Active, not recruiting	40 Years	85 Years	All	70	Phase 1	Netherlands

First Previous1Next Last